JPMorgan Chase & Co. Reduces Position in Healthpeak Properties, Inc. (NYSE:DOC)

JPMorgan Chase & Co. lowered its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 8.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,666,516 shares of the real estate investment trust’s stock after selling 1,895,124 shares during the period. JPMorgan Chase & Co. owned 2.81% of Healthpeak Properties worth $398,640,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Harvest Fund Management Co. Ltd purchased a new position in Healthpeak Properties in the 4th quarter worth $30,000. Groupama Asset Managment acquired a new position in shares of Healthpeak Properties in the third quarter valued at about $37,000. Continuum Advisory LLC purchased a new position in shares of Healthpeak Properties in the third quarter worth about $44,000. AdvisorNet Financial Inc lifted its holdings in shares of Healthpeak Properties by 34.5% during the fourth quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock worth $44,000 after purchasing an additional 563 shares during the period. Finally, Kestra Investment Management LLC purchased a new stake in Healthpeak Properties in the fourth quarter valued at approximately $45,000. 93.57% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have issued reports on DOC. Wells Fargo & Company reduced their price target on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 10th. Wedbush decreased their target price on shares of Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, February 14th. Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target on the stock in a research report on Wednesday, January 15th. StockNews.com raised Healthpeak Properties from a “sell” rating to a “hold” rating in a report on Saturday, March 22nd. Finally, Mizuho dropped their target price on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Thursday, December 5th. Four investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, Healthpeak Properties has an average rating of “Moderate Buy” and a consensus price target of $23.92.

Healthpeak Properties Stock Down 0.1 %

DOC stock opened at $20.20 on Friday. The stock has a market capitalization of $14.13 billion, a P/E ratio of 57.70, a P/E/G ratio of 2.17 and a beta of 1.14. Healthpeak Properties, Inc. has a 52 week low of $17.80 and a 52 week high of $23.26. The firm has a 50-day simple moving average of $20.23 and a 200-day simple moving average of $21.10. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96.

Healthpeak Properties Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th were paid a dividend of $0.305 per share. This is a positive change from Healthpeak Properties’s previous quarterly dividend of $0.30. This represents a $1.22 annualized dividend and a yield of 6.04%. The ex-dividend date of this dividend was Friday, February 14th. Healthpeak Properties’s payout ratio is 348.57%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.